I Institut Curie
Updates & Highlights
genomeweb.com · 10 days ago
One Biosciences, Institut Curie to Develop TNBC Single-Cell Dx Assay With €3.3M in French Funding
BioSpace · 10 days ago
One Biosciences Receives €3,3 Million Funding Under i-Démo 5 From France 2030 to Accelerate Development of First Single-Cell Diagnostic for Triple-Negative Breast Cancer, in Collaboration With Institut Curie
sttinfo.fi · 10 days ago
One Biosciences Receives €3,3 Million Funding Under i-Démo 5 From France 2030 to Accelerate Development of First Single-Cell Diagnostic for Triple-Negative Breast Cancer, in Collaboration With Institut Curie
Recent Openings
View all 1 jobs arrow_forwardAll Jobs
Culture & Mission
Benefits & Perks
Learning Budget
Professional development
Parental Leave
Family-friendly policies
Competitive Salary
Market-rate compensation
Equity/Stock Options
Ownership in the company
Health Insurance
Medical, dental & vision
Remote Work
Work from anywhere flexibility
Tech Stack
Core Values
Innovation
Pushing boundaries in AI/ML technology
Collaboration
Working together to achieve more
Excellence
Striving for the highest quality
Impact
Making a difference in the world
Office Locations
Team
Are you on the team at Institut Curie?
Claim this company page to verify ownership, edit details, and respond to applicants.
Claim this company arrow_forwardNews & Press
20 recentOne Biosciences, Institut Curie to Develop TNBC Single-Cell Dx Assay With €3.3M in French Funding
One Biosciences, Institut Curie to Develop TNBC Single-Cell Dx Assay With €3.3M in French Funding
genomeweb.com · 10 days ago
One Biosciences Receives €3,3 Million Funding Under i-Démo 5 From France 2030 to Accelerate Development of First Single-Cell Diagnostic for Triple-Negative Breast Cancer, in Collaboration With Institut Curie
One Biosciences Receives €3,3 Million Funding Under i-Démo 5 From France 2030 to Accelerate Development of First Single-Cell Diagnostic for Triple-Negative Breast Cancer, in Collaboration With Institut Curie
BioSpace · 10 days ago
One Biosciences Receives €3,3 Million Funding Under i-Démo 5 From France 2030 to Accelerate Development of First Single-Cell Diagnostic for Triple-Negative Breast Cancer, in Collaboration With Institut Curie
One Biosciences Receives €3,3 Million Funding Under i-Démo 5 From France 2030 to Accelerate Development of First Single-Cell Diagnostic for Triple-Negative Breast Cancer, in Collaboration With Institut Curie
sttinfo.fi · 10 days ago
Professor Steven Le Gouill Reappointed as Head of Institut Curie Hospitals
Professor Steven Le Gouill Reappointed as Head of Institut Curie Hospitals
Institut Curie · 13 days ago
Institut Curie calls for strengthened HPV vaccination among middle school students to prevent thousands of cancers
Institut Curie calls for strengthened HPV vaccination among middle school students to prevent thousands of cancers
Institut Curie · 20 days ago
Breast cancers: tumors-on-a-chip, a new ultra-personalized technology to guide therapeutic decisions - Institut Curie
Breast cancers: tumors-on-a-chip, a new ultra-personalized technology to guide therapeutic decisions - Institut Curie
Espace presse · 22 days ago
Breast cancers: tumors-on-a-chip, a new ultra-personalized technology to guide therapeutic decisions - Institut Curie
Breast cancers: tumors-on-a-chip, a new ultra-personalized technology to guide therapeutic decisions - Institut Curie
Espace presse · 23 days ago
The Institut Pasteur and the Institut Curie sign a new strategic agreement that holds great potential for French research
The Institut Pasteur and the Institut Curie sign a new strategic agreement that holds great potential for French research
Institut Pasteur · 29 days ago
Institut Curie Number of Employees 2026 | Employee Count & Headcount Data
Institut Curie Number of Employees 2026 | Employee Count & Headcount Data
Revelio Labs · about 2 months ago
New Study Focuses on the Mechanism of Cardiac Contraction - Institut Curie
New Study Focuses on the Mechanism of Cardiac Contraction - Institut Curie
Espace presse · 2 months ago
Circulating Biomarkers: Additional Evidence Supporting Their Clinical Use in Breast Cancer - Institut Curie
Circulating Biomarkers: Additional Evidence Supporting Their Clinical Use in Breast Cancer - Institut Curie
Espace presse · 4 months ago
A Promising Avenue for Treating Metastatic Ocular Melanoma Through the Combination of Two Targeted Therapies - Institut Curie
A Promising Avenue for Treating Metastatic Ocular Melanoma Through the Combination of Two Targeted Therapies - Institut Curie
Espace presse · 4 months ago
ASCO 2026 / Breast Cancer: Biological Avatars to Predict the Effectiveness and Adapt Treatments to Each Patient - Institut Curie
ASCO 2026 / Breast Cancer: Biological Avatars to Predict the Effectiveness and Adapt Treatments to Each Patient - Institut Curie
Espace presse · 4 months ago
Circulating Biomarkers, Biological Avatars, Innovative Imaging, Remote Monitoring… Institut Curie at the Heart of the Announcements at the 2026 ASCO Conference.
Circulating Biomarkers, Biological Avatars, Innovative Imaging, Remote Monitoring… Institut Curie at the Heart of the Announcements at the 2026 ASCO Conference.
Institut Curie · 4 months ago
Thales : With Institut Curie, Thales is putting its critical technologies to work in the fight against cancer
Thales : With Institut Curie, Thales is putting its critical technologies to work in the fight against cancer
marketscreener.com · 4 months ago
With Institut Curie, Thales is putting its critical technologies to work in the fight against cancer
With Institut Curie, Thales is putting its critical technologies to work in the fight against cancer
Thales · 4 months ago
Dangerous Links Between Cancer Cells and Tumor Microenvironment in Lobular Breast Cancers - Institut Curie
Dangerous Links Between Cancer Cells and Tumor Microenvironment in Lobular Breast Cancers - Institut Curie
Espace presse · 4 months ago
"Everyone Protected Against HPV": Institut Curie Launches Its Prevention Campaign Against Papillomavirus-Related Cancers
"Everyone Protected Against HPV": Institut Curie Launches Its Prevention Campaign Against Papillomavirus-Related Cancers
Institut Curie · 5 months ago
Institut Curie, the CEA and Thales Sign a Partnership to Build a Unique FLASH Radiotherapy Platform to Accelerate the Cure for Cancers Throughout the World
Institut Curie, the CEA and Thales Sign a Partnership to Build a Unique FLASH Radiotherapy Platform to Accelerate the Cure for Cancers Throughout the World
marketscreener.com · 5 months ago
Institut Curie spotlights innovation in its series "Tech Talk: The Innovation Café" featuring Dr. Isabelle Fromantin
Institut Curie spotlights innovation in its series "Tech Talk: The Innovation Café" featuring Dr. Isabelle Fromantin
Institut Curie · 5 months ago